Pain affects the lives of millions of Americans every day and improving pain care and the lives of patients with pain is a public health imperative.
Roche says it is undeterred by upcoming biosimilar threat to Vabysmo
Roche’s competition in the eye disease space is intensifying with Regeneron’s high-dose Eylea and a looming biosimilar challenge, but the Swiss pharma said its blockbuster